Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Maxcyte (MXCT) Assets Average (2021 - 2026)

Maxcyte has reported Assets Average over the past 5 years, most recently at $208.0 million for Q4 2025.

  • Quarterly Assets Average fell 14.77% to $208.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $208.0 million through Dec 2025, down 14.77% year-over-year, with the annual reading at $221.0 million for FY2025, 12.95% down from the prior year.
  • Assets Average was $208.0 million for Q4 2025 at Maxcyte, down from $216.6 million in the prior quarter.
  • Over five years, Assets Average peaked at $290.4 million in Q2 2022 and troughed at $185.4 million in Q3 2021.
  • The 5-year median for Assets Average is $265.3 million (2023), against an average of $256.2 million.
  • Year-over-year, Assets Average surged 55.38% in 2022 and then dropped 14.77% in 2025.
  • A 5-year view of Assets Average shows it stood at $280.9 million in 2021, then grew by 2.0% to $286.5 million in 2022, then dropped by 6.64% to $267.5 million in 2023, then dropped by 8.77% to $244.0 million in 2024, then dropped by 14.77% to $208.0 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Assets Average are $208.0 million (Q4 2025), $216.6 million (Q3 2025), and $224.9 million (Q2 2025).